Literature DB >> 1667256

Stimulation with cytokines enhances penetration of azithromycin into human macrophages.

L E Bermudez1, C Inderlied, L S Young.   

Abstract

An effective intracellular concentration of an antimicrobial agent is essential for therapy of infections caused by organisms of the Mycobacterium avium complex. We previously reported on the effect of the combination of azithromycin and tumor necrosis factor (TNF) against M. avium infection in macrophages. We now report that stimulation of macrophages either with recombinant human gamma interferon (IFN-gamma, 10(2) U/ml) or with recombinant human TNF-alpha (10(2) U/ml) resulted in an increase in the intracellular concentration of azithromycin by approximately 200% within 3 h, compared with the concentration in unstimulated macrophages. Infection of macrophages with M. avium complex led to a decrease in the uptake of [14C]azithromycin by infected cells, compared with that by uninfected controls. Stimulation of infected macrophages with recombinant IFN-gamma or TNF-alpha overcame the inhibitory effect associated with infection. These results suggest that the increased bactericidal activity of the TNF-alpha-azithromycin or IFN-gamma-azithromycin combination against M. avium is related to enhanced uptake of the antibiotic by the stimulated phagocyte.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1667256      PMCID: PMC245442          DOI: 10.1128/AAC.35.12.2625

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

1.  In vitro and in vivo activity of azithromycin (CP 62,993) against the Mycobacterium avium complex.

Authors:  C B Inderlied; P T Kolonoski; M Wu; L S Young
Journal:  J Infect Dis       Date:  1989-05       Impact factor: 5.226

2.  Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms.

Authors:  J Retsema; A Girard; W Schelkly; M Manousos; M Anderson; G Bright; R Borovoy; L Brennan; R Mason
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

3.  Pulmonary disease due to Mycobacterium intracellulare.

Authors:  H Yeager; J W Raleigh
Journal:  Am Rev Respir Dis       Date:  1973-09

4.  Mycobacterium avium complex infection in patients with the acquired immunodeficiency syndrome. A clinicopathologic study.

Authors:  J M Wallace; J B Hannah
Journal:  Chest       Date:  1988-05       Impact factor: 9.410

5.  In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection.

Authors:  R P Gladue; G M Bright; R E Isaacson; M F Newborg
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

6.  Pathology of Mycobacterium avium-intracellulare infection in acquired immunodeficiency syndrome.

Authors:  E C Klatt; D F Jensen; P R Meyer
Journal:  Hum Pathol       Date:  1987-07       Impact factor: 3.466

Review 7.  Mycobacterial infections in AIDS patients, with an emphasis on the Mycobacterium avium complex.

Authors:  L S Young; C B Inderlied; O G Berlin; M S Gottlieb
Journal:  Rev Infect Dis       Date:  1986 Nov-Dec

8.  Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex.

Authors:  L E Bermudez; L S Young
Journal:  J Immunol       Date:  1988-05-01       Impact factor: 5.422

9.  Phagocytosis and intracellular killing of Mycobacterium avium complex by human and murine macrophages.

Authors:  L E Bermudez; L S Young
Journal:  Braz J Med Biol Res       Date:  1987       Impact factor: 2.590

10.  Determination of in vitro susceptibility of Mycobacterium avium complex isolates to antimycobacterial agents by various methods.

Authors:  C B Inderlied; L S Young; J K Yamada
Journal:  Antimicrob Agents Chemother       Date:  1987-11       Impact factor: 5.191

View more
  14 in total

Review 1.  Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"?

Authors:  M T Labro
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

2.  Effect of proinflammatory cytokines on the interplay between roxithromycin, HMR 3647, or HMR 3004 and human polymorphonuclear neutrophils.

Authors:  D Vazifeh; A Bryskier; M T Labro
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

3.  Effect of granulocyte colony-stimulating factor on the candidacidal activity of polymorphonuclear neutrophils and their collaboration with fluconazole.

Authors:  U Natarajan; E Brummer; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

4.  Intracellular and extracellular penetration of azithromycin into inflammatory and noninflammatory blister fluid.

Authors:  C D Freeman; C H Nightingale; D P Nicolau; P P Belliveau; M A Banevicius; R Quintiliani
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191

5.  A bone marrow-derived murine macrophage model for evaluating efficacy of antimycobacterial drugs under relevant physiological conditions.

Authors:  P S Skinner; S K Furney; M R Jacobs; G Klopman; J J Ellner; I M Orme
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

6.  Mycobacterium avium-intracellulare contamination of mammalian cell cultures.

Authors:  I H Lelong-Rebel; Y Piemont; M Fabre; G Rebel
Journal:  In Vitro Cell Dev Biol Anim       Date:  2008-10-15       Impact factor: 2.416

7.  Azithromycin pharmacokinetics and intracellular concentrations in Legionella pneumophila-infected and uninfected guinea pigs and their alveolar macrophages.

Authors:  D A Stamler; M A Edelstein; P H Edelstein
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

Review 8.  Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy.

Authors:  D H Peters; H A Friedel; D McTavish
Journal:  Drugs       Date:  1992-11       Impact factor: 9.546

9.  In vitro and in vivo intraleukocytic accumulation of azithromycin (CP-62, 993) and its influence on ex vivo leukocyte chemiluminescence.

Authors:  M Bonnet; P Van der Auwera
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

Review 10.  Heterogeneity in the granulomatous response to mycobacterial infection in patients with defined genetic mutations in the interleukin 12-dependent interferon-gamma production pathway.

Authors:  David A Lammas; E De Heer; J D Edgar; V Novelli; A Ben-Smith; R Baretto; P Drysdale; J Binch; C MacLennan; D S Kumararatne; S Panchalingam; T H M Ottenhoff; J-L Casanova; J F Emile
Journal:  Int J Exp Pathol       Date:  2002-02       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.